Home

Norris Medicines Ltd EPS

Image

Norris Medicines Ltd

NSE: NORRISMEDICINES

EPS

₹ -0.83

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of Norris Medicines Ltd is ₹ -0.83 as of 21 Feb 25 .
  • The earning per share of Norris Medicines Ltd changed from ₹ -0.61 to ₹ -0.28 over 7 quarters. This represents a CAGR of -35.91% .

Historical Earning per Share of Norris Medicines Ltd

No data available

* All values are in

Company Fundamentals for Norris Medicines Ltd

Market Cap

20 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

0.0

Day’s High

20.48

Day’s Low

20.48

DTE

-1.5

ROE

5.7

52 Week High

27.74

52 Week Low

10.7

ROCE

-5.1

Market Price of Norris Medicines Ltd

1M

1Y

3Y

5Y

Monitoring Norris Medicines Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202520.48
20 Feb 202520.48
19 Feb 202520.58
18 Feb 202521
17 Feb 202521
14 Feb 202521
13 Feb 202521.4
12 Feb 202521.56
11 Feb 202521.76
10 Feb 202521.76

SWOT Analysis Of Norris Medicines Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Norris Medicines Ltd

Asset Value vs Market Value of Norris Medicines Ltd

Market Value

20

Asset Value

Value addition

1.8 X

7

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Norris Medicines Ltd20.48
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of Norris Medicines Ltd

No data available

* All values are in crore

Historical Revenue of Norris Medicines Ltd

No data available

* All values are in crore

Historical EBITDA of Norris Medicines Ltd

No data available

* All values are in crore

Historical Net Profit of Norris Medicines Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Norris Medicines Ltd News Hub

Norris Medicines reports standalone net loss of Rs 0.37 crore in the June 2024 quarter

Net Loss of Norris Medicines reported to Rs 0.37 crore in the quarter ended June 2024 as against net

Read more

16 Aug 24

Norris Medicines to discuss results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 August 2024. Pow

Read more

09 Aug 24

Norris Medicines to conduct AGM

Norris Medicines announced that the 33th Annual General Meeting (AGM) of the company will be held on

Read more

16 Sept 24

Norris Medicines to table results

Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 November 2024 Po

Read more

12 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Norris Medicines Ltd

What is the EPS of Norris Medicines Ltd stock?

The Earnings Per Share (EPS) of Norris Medicines Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Norris Medicines Ltd EPS calculated?

The EPS of Norris Medicines Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Norris Medicines Ltd report its EPS?

Norris Medicines Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Norris Medicines Ltd EPS?

Factors that influence the EPS of Norris Medicines Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Norris Medicines Ltd EPS growth indicate future performance?

Yes, consistent growth in Norris Medicines Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions